Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
Gyre Therapeutics, Inc. (GYRE) had Cash Flow from Investing Activities of $-0.47M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$116.59M |
|
$5.03M |
|
$5.42M |
|
$111.17M |
|
$105.10M |
|
$11.49M |
|
$2.95M |
|
$14.44M |
|
$14.44M |
|
$9.88M |
|
$9.88M |
|
$9.88M |
|
$9.88M |
|
$11.49M |
|
$14.01M |
|
89.34M |
|
103.18M |
|
$0.06 |
|
$0.02 |
|
| Balance Sheet Financials | |
$102.37M |
|
$23.60M |
|
$63.76M |
|
$166.13M |
|
$18.29M |
|
-- |
|
$5.56M |
|
$23.85M |
|
$142.28M |
|
$136.13M |
|
$142.28M |
|
91.31M |
|
| Cash Flow Statement Financials | |
$1.01M |
|
|
Cash Flow from Investing Activities |
$-0.47M |
$24.38M |
|
$11.81M |
|
$37.07M |
|
$25.26M |
|
$7.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.60 |
|
-- |
|
-- |
|
-- |
|
-- |
|
95.35% |
|
9.85% |
|
9.85% |
|
12.01% |
|
12.38% |
|
4.31% |
|
$-0.15M |
|
-- |
|
-- |
|
-- |
|
0.70 |
|
0.53 |
|
3.72 |
|
98.02 |
|
6.94% |
|
7.26% |
|
5.95% |
|
6.94% |
|
$1.56 |
|
$-0.00 |
|
$0.01 |
|